HR
Henrijette Richter
Managing Partner at Sofinnova Partners
Copenhagen, Capital Region of Denmark
Overview
Henrijette Richter is the Managing Partner at Sofinnova Partners, with a strong background in investments and finance within the lifesciences and biotechnology sectors. She has played a key role in funding and supporting start-ups through various stages, including Series A investments, and has served on the boards of multiple successful companies like Asceneuron and NodThera Limited.
Work Experience
Managing Partner
2017 - Current
Partner
2014 - 2017
Board Member
2021
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Raised $80,000,000.00 from Ono Venture Investment, UPMC Enterprises, Pfizer Venture Investments, AbbVie, ARCH Venture Partners, Leaps by Bayer, Alexandria Venture Investments, Eli Lilly, MRL Ventures Fund and Sofinnova Partners.
Board Member
2020
Board Member
2020
Board Member
2021
Board Member
2021
Board Member
2019
Board Member
2019
Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases.
Raised $66,779,837.00 from Astellas Venture Management.
Board Member
2019
Chair Of The Board Of Directors
2018 - 2019
Member of The Supervisory Board
2019
Chair Of The Board Of Directors
2016 - 2019
Board Member
2015
Member Board Of Directors
2017 - 2021
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Raised $28,500,000.00 from Inkef, Canaan Partners, Sofinnova Partners and Mission BioCapital.
Member Board of Directors
2014 - 2017
Education
executive course
2008 - 2008
Executive Certificate
2005 - 2006
Postdoctoral Fellow
2002 - 2004
PhD
1999 - 2002
MSc
1991 - 1999